'Some Hope Is Better Than Having No Hope'

Lise Davidsen is one of the greatest opera singers of our time — a soprano with a voice so rare, critics reach back a century for comparison. This spring, she has been starring in a sold-out new production of Wagner’s “Tristan und Isolde” at the Metropolitan Opera. But she’s also ...  Show more

Did President Trump fall for the myth of surgical warfare? Gen. Stanley McChrystal joins the columnist David French, both veterans of the Iraq War, to discuss what may have been overlooked in the planning of Operation Epic Fury. McChrystal, who retired from the Army in 2010, argu ...  Show more

For many years, pharmaceutical companies have tried and failed to find a treatment to slow symptoms of ALS–the debilitating, fatal illness also known as Lou Gehrig’s Disease. A potentially promising new drug from Biogen may offer some relief to those afflicted with an uncommon an ...  Show more

The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. Rhitu Chatterjee talks with science correspondent Jon Hamilton about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it. For ...  Show more

Aduhelm, known generically as aducanumab, is the first drug to actually affect the underlying disease process associated with Alzheimer's. Yet sales have been limited, and the drug is reaching very few patients — at least so far. It's expensive, risky and likely doing little to i ...  Show more

An overwhelming demand for ADHD diagnoses has left the NHS struggling to keep up. What’s behind the rise?

Content warning: This episode contains mentions of suicidal thoughts and eating disorders.

This podcast was brought to you thanks to the s ...